Beike Biotech Launches New International Stem Cell Venture

“Beike Holdings Limited”, a Strategic Joint Venture With Bangkok-Based SiriCell Technologies, Inc., Will Support the Rapid Clinical Translation of Stem Cell Therapies & Regulatory Approval Outside of China SHENZHEN, China,…

New Study Demonstrates Improvements in Lupus Patients Receiving Stem Cell Therapies

Lupus study shows promising results using umbilical cord mesenchymal stem cells. NANJING, Jiangsu, China, June 7, 2010 /PRNewswire-Asia/ — A new study shows that umbilical cord mesenchymal stem cell transplant…

Beike Biotechnology Opens World’s Largest Stem Cell Storage and Processing Facility

Leading Chinese Stem Cell Therapy Provider Expands Capacity Ahead of Schedule TAIZHOU, China, May 11 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the world’s leading biotechnology companies focusing on…

Beike Biotechnology Receives International Recognition for Quality Control Processes

Leading Chinese Stem Cell Therapy Provider Awarded Three ISO9001 Certifications for Stem Cell Technology Quality Management System TAIZHOU, China, April 2 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the…

Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials

TAIZHOU, Jiangsu, China, January 6 – The Jiangsu Government’s Science and Technology Department has announced a $1.8 million grant – the Jiangsu Technological Achievements Transformational Grant – to support the…

Beike CSO Speaks at IPA Diabetic Foot Care Conference, India

NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ — Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com ), spoke at a conference on High-Risk Diabetic…


1 2 6 7 8 9